Literature DB >> 25296095

Early HIV-1 infection is associated with reduced frequencies of cervical Th17 cells.

Lyle R McKinnon1, Billy Nyanga, Connie J Kim, Preston Izulla, Jessie Kwatampora, Makobu Kimani, Kamnoosh Shahabi, Nelly Mugo, Jennifer S Smith, A Omu Anzala, Joshua Kimani, Rupert Kaul.   

Abstract

BACKGROUND: The hallmark of HIV infection is progressive but variable rates of systemic and mucosal CD4 depletion, leading to immunodeficiency. The impact of early HIV infection on cervical CD4 T-cell populations in humans remains poorly described.
METHODS: We analyzed cytobrush-derived immune cells by flow cytometry and cytokines in cervicovaginal lavage from participants in early HIV (<6 months postinfection), chronic HIV, and HIV-uninfected controls.
RESULTS: CD4:CD8 ratios declined rapidly in both the cervix and the blood following HIV infection. In contrast, absolute cervical CD4 T-cell counts in early HIV were comparable to HIV-uninfected participants, declining only in chronic infection. Early HIV infection was associated with increases in RANTES and MIP3a in cervicovaginal fluids. Concurrently, slight increases in activated cells (CD38HLA-DR) and higher levels of CTLA4 expression on Tregs in the cervix were observed. Although study groups did not differ with respect to levels of CCR5, integrin B7, or CD69, the frequencies of Th17 cells (defined as CCR6CCR10) was reduced by >10-fold in early HIV infection and Th1 cells (defined as CCR6CXCR3) were reduced by >2-fold. Although CCR6CCR10 cells did not differ in HIV receptor expression, these cells produced higher levels of interferon gamma and interleukin 17.
CONCLUSIONS: These data support the model of initial CD4 T-cell depletion followed by overall T-cell influx in response to infection and concomitant increases in immune activation, inflammation, and regulatory markers. These data are among the earliest characterization of the cellular milieu in the female genital tract following male-to-female HIV transmission.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25296095     DOI: 10.1097/QAI.0000000000000389

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  28 in total

Review 1.  Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.

Authors:  Nadia R Roan; Martin R Jakobsen
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 2.  Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.

Authors:  Florent Colomb; Leila B Giron; Irena Trbojevic-Akmacic; Gordan Lauc; Mohamed Abdel-Mohsen
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

3.  Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells.

Authors:  Kelly B Arnold; Adam Burgener; Kenzie Birse; Laura Romas; Laura J Dunphy; Kamnoosh Shahabi; Max Abou; Garrett R Westmacott; Stuart McCorrister; Jessie Kwatampora; Billy Nyanga; Joshua Kimani; Lindi Masson; Lenine J Liebenberg; Salim S Abdool Karim; Jo-Ann S Passmore; Douglas A Lauffenburger; Rupert Kaul; Lyle R McKinnon
Journal:  Mucosal Immunol       Date:  2015-06-24       Impact factor: 7.313

4.  Parallel studies of mucosal immunity in the reproductive and gastrointestinal mucosa of HIV-infected women.

Authors:  Uma Shanmugasundaram; J William Critchfield; Linda C Giudice; Karen Smith-McCune; Ruth M Greenblatt; Barbara L Shacklett
Journal:  Am J Reprod Immunol       Date:  2020-05-08       Impact factor: 3.886

Review 5.  The Penis, the Vagina and HIV Risk: Key Differences (Aside from the Obvious).

Authors:  Rupert Kaul; Cindy M Liu; Daniel E Park; Ronald M Galiwango; Aaron A R Tobian; Jessica L Prodger
Journal:  Viruses       Date:  2022-05-27       Impact factor: 5.818

6.  Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

Authors:  Christine Mauck; Pai-Lien Chen; Charles S Morrison; Raina N Fichorova; Cynthia Kwok; Tsungai Chipato; Robert A Salata; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-26       Impact factor: 2.205

Review 7.  Microbial translocation and microbiome dysbiosis in HIV-associated immune activation.

Authors:  Alexander S Zevin; Lyle McKinnon; Adam Burgener; Nichole R Klatt
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

8.  Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.

Authors:  Vineet Joag; Onyango Obila; Pawel Gajer; Milcah Carol Scott; Sara Dizzell; Michael Humphrys; Kamnoosh Shahabi; Sanja Huibner; Brett Shannon; Wangari Tharao; Marianne Mureithi; Julius Oyugi; Joshua Kimani; Charu Kaushic; Jacques Ravel; Omu Anzala; Rupert Kaul
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

9.  Altered Immune Cytokine Expression Associated with KoRV B Infection and Season in Captive Koalas.

Authors:  Iona E Maher; Damien P Higgins
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

10.  Th17 T Cells and Immature Dendritic Cells Are the Preferential Initial Targets after Rectal Challenge with a Simian Immunodeficiency Virus-Based Replication-Defective Dual-Reporter Vector.

Authors:  Danijela Maric; Wesley A Grimm; Natalie Greco; Michael D McRaven; Angela J Fought; Ronald S Veazey; Thomas J Hope
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.